Viewing Study NCT05452304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-04-12 @ 4:00 PM
Study NCT ID: NCT05452304
Status: COMPLETED
Last Update Posted: 2025-12-03
First Post: 2022-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Subjects View
None Crohns Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD7798 View
None Single ascending dose View
None Repeat dose View
None Sentinel dosing View